A prevention-focused co-founded by the head of a Stanford research lab is making an expensive bet with its latest fundraise: that it can build a better full-body scanner than medical device behemoths selling MRIs to health systems.
Q Bio raised $27 million in “strategic funding” from existing investors including Khosla Ventures, Andreessen Horowitz, and Founders Fund, the company told STAT. The venture arm of Canadian tech company TELUS, which sells products ranging from telehealth to cell phone service, joined as a new investor. Mike Snyder, a Stanford genetics professor who leads a lab focused on genomics, personalized medicine and early disease detection, co-founded the company.
The funding, executives tell STAT, will go toward manufacturing of Q Bio’s full-body scanner, Mark I, which is intended to be more comfortable, open, quick and comprehensive compared to a traditional MRI scanner.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect